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"Different Strokes"
A management dilemma *Arunodaya R. Gujjar, 1 Mortada El-Tigani, 2 Darshan Lal, 2 Anupam K. Kakaria, 3 Abdullah R. Al-Asmi A 55-year-old African woman initially presented to a secondary hospital in Muscat, Oman, in 2015 with drooping of the left eyelid which had begun a few hours previously. The patient reported a history of double vision. She was being treated for hypertension with amlodipine, which she had taken for the past 20 years, although with poor compliance. Upon examination, she was observed to have an elevated blood pressure of 180/120 mmHg. A neurological examination revealed left ptosis with a dilated pupil which reacted sluggishly to light and limited movements of the left eye, except for abduction [ Figure 1A ]. Her blood glucose and haemoglobin levels, cell counts and erythrocyte sedimentation rate (ESR) were all normal. A computed tomography (CT) scan of the brain showed hypodensities in the brainstem and periventricular regions [ Figure 1B ]. She was prescribed amlodipine, telmisartan, atenolol, aspirin and atorvastatin before being discharged, with advice to take her medication regularly.
Subsequently, 10 days later, the patient was admitted to the Emergency Department of the Sultan Qaboos University Hospital, a tertiary hospital in Muscat. According to her relatives, she had been speaking on the phone at home before suddenly dropping the phone from her right hand and slumping over. She had remained conscious, but was noted to have right-sided weakness and slurred speech. At presentation, her blood pressure was 165/110 mmHg. She was alert, oriented and appeared able to comprehend and answer questions, although her speech continued to be slurred. The ptosis and ophthalmoparesis in the left eye persisted, while the movement, pupil and visual fields of the right eye were normal. New neurological signs were evident, including right upper motor neuron facial paresis, dense right-sided hemiparesis with a power of 0-1/5 on the Medical Research Council muscle power scale in both the right upper and lower limbs [ Figure 2 ], reduced touch and pinprick sensations over the right side of the body and face and right extensor plantar responses. Her tendon reflexes on the right side were brisk over the course of the next couple of days. A susceptibility-weighted MRI sequence, which is sensitive to haemorrhages, displayed hypointensities scattered in the deep ganglionic and periventricular regions and the brainstem [ Figure 4A ], in addition to a large haematoma. Magnetic resonance angiography confirmed that the cervical carotid and vertebral arteries were normal, with some irregularities in the intracranial arteries, suggestive of atherosclerosis [ Figure 4B ]. However, no aneurysms or vascular malformations were observed.
Following these findings, aspirin and atorvastatin were discontinued and the patient received intravenous labetalol for emergent control of her hypertension; later, other oral antihypertensive agents were prescribed and physiotherapy was initiated. A week after the onset of the right-sided hemiparesis, the patient reported diffuse aching pain over the right side of her body, including the face. The pain was present throughout the day and disturbed her sleep. Fortunately, it improved gradually following the administration of oral pregabalin. The patient was discharged two weeks after admission with persistent right-sided weakness and sensory impairment. At a follow-up appointment one year later, the ophthalmoparesis and lower limb weakness had improved significantly, although she continued to experience weakness in the right arm.
Discussion
The aforementioned case describes a middle-aged woman with a long history of poorly-controlled hypertension who experienced two varieties of stroke sequentially within a few days-ischaemic stroke followed by intracerebral haemorrhage-leading to crossed hemiparesis syndrome causing ptosis and ophthalmoparesis on the left side, followed by hemiparesis and hemihypoesthesia on the right side with preserved speech function. This patient was unique in several aspects. Over the course of 10 days, she had sequential neurological deficits which initially seemed consistent with Weber's syndrome, but which were in fact due to a combination of two different stroke mechanisms, with third nerve palsy likely due to a midbrain lacune and contralateral hemiparesis due to a left thalamocapsular haematoma. This unusual sequence of events resulted in a picture of pseudoWeber's syndrome, as the responsible events were distinct and separated by time as well as location. The patient also developed thalamic pain syndrome shortly after an episode of deep ganglionic haemorrhage.
Cerebral small vessel disease (CSVD) is a fairly common vascular syndrome in which hypertension is the main risk factor, with others being age and the presence of diabetes mellitus. 3, 5, 9 While the disease can remain 'silent' for long periods of time, it commonly manifests as white matter and periventricular MRI hyperintensities, lacunar infarcts, microhaemorrhages and hypertensive intracerebral haemorrhage, as demonstrated in the current case. 5, 9 Such changes are typically clustered deep in the brain in the territory supplied by the penetrating end arteries arising from the circle of Willis. In addition, CSVD may be associated with progressive cognitive, gait, mood and bladder function changes. 3 Overall, CSVD is the cause of approximately onefifth of all stroke cases and up to 45% of dementias. 3 Lacunar stroke constitutes 15-25% of all stroke cases, while intracerebral haemorrhage accounts for 10-15%. 1 Cerebral amyloid angiopathy is the main differential diagnosis and may have similar manifestations. 3, 5 Nonhypertensive lobar haemorrhages are often recurrent and typical of amyloid angiopathy, along with MRI evidence of white matter hyperintensities and microhaemorrhages which are more prominent in the peripheral subcortical regions of the hemispheres. Superficial siderosis on the cortical surface is also a feature of amyloid angiopathy, sometimes leading to focal seizures. 3, 5 Together with hyperintensities, the deposition of amyloid in the brain is known to occur in several degenerative disorders of the brain, the most prominent of which is Alzheimer's disease, with no specific treatment known to date. Inherited small vessel disease includes cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and Fabry disease; autoimmune vasculitis and irradiation may also cause small vessel disease. 3, 5 A family history of similar or related manifestations, onset in young non-hypertensive individuals, prominent headaches, imaging evidence of vasculopathy and cerebrospinal fluid abnormalities may assist in the diagnosis. Other than for a few specific conditions (i.e. Fabry disease or cerebral angiitis), the treatment and prevention of the progression of many of these conditions is still poorly understood. 3, 5 Few studies to date have addressed the management of CSVD as a whole. Effective long-term hypertension control is considered the main method of preventing CSVD progression. 7 Several therapeutic trials addressing stroke or dementia have included individual components of CSVD, thereby providing some evidence for the efficacy of certain interventions. 3, 7 Thrombolysis is known to be of benefit for patients with acute lacunar stroke, although CSVD may be associated with a higher risk of intracerebral haemorrhage. 10 The efficacy of antiplatelet agents among patients with CSVD is unclear. 3, 6, 7 In the double-blind Secondary Prevention of Small Subcortical Strokes trial, no difference in stroke prevention was observed among patients undergoing dual antiplatelet therapy (aspirin with clopidogrel) compared to those taking aspirin and a placebo; in fact, there was a greater risk of haemorrhage and death with dual antiplatelet therapy. 6 Another study demonstrated a significant reduction in recurrent stroke among patients, most of whom had lacunar stroke, treated with cilostazol rather than a placebo (relative risk: 41.7%; P <0.015). 11 Thus, it is possible that antiplatelet agents may be of benefit among patients with CSVD who present with lacunar stroke.
Patients with intracerebral haemorrhage due to CSVD are treated similarly to those due to other primary causes of intracerebral hemorrhage.
11 How-ever, no studies or guidelines have addressed the management of patients with CSVD who present with sequential ischaemic and haemorrhagic stroke, as in the current case. In the context of intracerebral haemorrhage, antiplatelet agents are conventionally withheld for a period of between a few weeks to three months. Later, the reintroduction of antiplatelet agents may often be indicated by a coexisting risk of ischaemic stroke, ischaemic heart disease or peripheral arterial disease. 12 While lacunar stroke is recognised as a risk factor for stroke recurrence and may require antiplatelet therapy, no studies address the issue of whether and when to reintroduce this therapy in cases of sequential ischaemic and haemorrhagic stroke. 6, 7 Therefore, in the absence of other risk factors for ischaemic events and due to the presence of significant cerebral microhaemorrhages as well as a haematoma, management of the patient in the current case consisted solely of hypertension control. No stroke recurrence was observed over the following year.
Conclusion
This article describes a patient with crossed hemiparesis syndrome-left third nerve palsy with rightsided hemiparesis-due to two distinct episodes of ischaemic and haemorrhagic stroke. The underlying causes were a lacunar infarct and thalamocapsular haemorrhage due to CSVD, which is a fairly common syndrome with diverse manifestations. For patients with recurrent stroke or multiple stroke syndromes, diligent clinical assessment is important in order to understand the location of each event as well as the underlying pathophysiological mechanism. a c k n o w l e d g e m e n t s
